NASACORT

LOE Approaching

triamcinolone acetonide

NDANASALAEROSOL, METERED
Approved
Jul 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
11

Clinical Trials (5)

NCT04598542Phase 1Completed

Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers

Started Oct 2020
NCT03317015Phase 3Completed

A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)

Started Nov 2016
260 enrolled
Rhinitis Allergic
NCT02294656Phase 1Completed

Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide

Started Nov 2014
4 enrolled
CYSTOID MACULAR EDEMA
NCT01154153Phase 4Completed

Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis

Started Jun 2010
140 enrolled
Rhinitis, Allergic, Perennial and/or Seasonal
NCT00449072Phase 4Completed

Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)

Started Mar 2007
299 enrolled
Rhinitis, Allergic, Perennial